Enteral nutrition drugs, also known as enteral nutrition preparations, are a generic term for a variety of products used in clinical enteral nutrition support, whose nutritional composition mainly includes a balance of various proteins, amino acids, sugars, fats, vitamins, minerals, dietary fibre, etc. The raw materials are mainly derived from terrestrial animal and plant extracts.

The global market for Enteral Nutrition Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enteral Nutrition Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Enteral Nutrition Drug by region & country, by Type, and by Application.

The Enteral Nutrition Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enteral Nutrition Drug.

Market Segmentation

Scope of Enteral Nutrition Drug - Market Report

Report Metric	Details
Report Name	Enteral Nutrition Drug - Market
CAGR	5%
Segment by Type:	Adults Children
Segment by Application	Hospitals Clinics Pharmaceutical Companies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Hospira Inc, Fresenius Kabi, Danone, Knowmedical, Nestlé, B. Braun Melsungen AG, Abbott, Otsuka Pharmaceutical India Private Limited, NUTRICHEM DIÄT + PHARMA GMBH, Delta Drugs, Baxter, Allergan, Actavis Inc., Grifols, S.A., Vifor Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Enteral Nutrition Drug manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Enteral Nutrition Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Enteral Nutrition Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Enteral Nutrition Drug - Market report?

Ans: The main players in the Enteral Nutrition Drug - Market are Hospira Inc, Fresenius Kabi, Danone, Knowmedical, Nestlé, B. Braun Melsungen AG, Abbott, Otsuka Pharmaceutical India Private Limited, NUTRICHEM DIÄT + PHARMA GMBH, Delta Drugs, Baxter, Allergan, Actavis Inc., Grifols, S.A., Vifor Pharma

What are the Application segmentation covered in the Enteral Nutrition Drug - Market report?

Ans: The Applications covered in the Enteral Nutrition Drug - Market report are Hospitals, Clinics, Pharmaceutical Companies, Others

What are the Type segmentation covered in the Enteral Nutrition Drug - Market report?

Ans: The Types covered in the Enteral Nutrition Drug - Market report are Adults, Children

1 Market Overview

1.1 Enteral Nutrition Drug Product Introduction

1.2 Global Enteral Nutrition Drug Market Size Forecast

1.3 Enteral Nutrition Drug Market Trends & Drivers

1.3.1 Enteral Nutrition Drug Industry Trends

1.3.2 Enteral Nutrition Drug Market Drivers & Opportunity

1.3.3 Enteral Nutrition Drug Market Challenges

1.3.4 Enteral Nutrition Drug Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Enteral Nutrition Drug Players Revenue Ranking (2023)

2.2 Global Enteral Nutrition Drug Revenue by Company (2019-2024)

2.3 Key Companies Enteral Nutrition Drug Manufacturing Base Distribution and Headquarters

2.4 Key Companies Enteral Nutrition Drug Product Offered

2.5 Key Companies Time to Begin Mass Production of Enteral Nutrition Drug

2.6 Enteral Nutrition Drug Market Competitive Analysis

2.6.1 Enteral Nutrition Drug Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Enteral Nutrition Drug Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enteral Nutrition Drug as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Adults

3.1.2 Children

3.2 Global Enteral Nutrition Drug Sales Value by Type

3.2.1 Global Enteral Nutrition Drug Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Enteral Nutrition Drug Sales Value, by Type (2019-2030)

3.2.3 Global Enteral Nutrition Drug Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Clinics

4.1.3 Pharmaceutical Companies

4.1.4 Others

4.2 Global Enteral Nutrition Drug Sales Value by Application

4.2.1 Global Enteral Nutrition Drug Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Enteral Nutrition Drug Sales Value, by Application (2019-2030)

4.2.3 Global Enteral Nutrition Drug Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Enteral Nutrition Drug Sales Value by Region

5.1.1 Global Enteral Nutrition Drug Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Enteral Nutrition Drug Sales Value by Region (2019-2024)

5.1.3 Global Enteral Nutrition Drug Sales Value by Region (2025-2030)

5.1.4 Global Enteral Nutrition Drug Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Enteral Nutrition Drug Sales Value, 2019-2030

5.2.2 North America Enteral Nutrition Drug Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Enteral Nutrition Drug Sales Value, 2019-2030

5.3.2 Europe Enteral Nutrition Drug Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Enteral Nutrition Drug Sales Value, 2019-2030

5.4.2 Asia Pacific Enteral Nutrition Drug Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Enteral Nutrition Drug Sales Value, 2019-2030

5.5.2 South America Enteral Nutrition Drug Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Enteral Nutrition Drug Sales Value, 2019-2030

5.6.2 Middle East & Africa Enteral Nutrition Drug Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Enteral Nutrition Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Enteral Nutrition Drug Sales Value

6.3 United States

6.3.1 United States Enteral Nutrition Drug Sales Value, 2019-2030

6.3.2 United States Enteral Nutrition Drug Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Enteral Nutrition Drug Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Enteral Nutrition Drug Sales Value, 2019-2030

6.4.2 Europe Enteral Nutrition Drug Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Enteral Nutrition Drug Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Enteral Nutrition Drug Sales Value, 2019-2030

6.5.2 China Enteral Nutrition Drug Sales Value by Type (%), 2023 VS 2030

6.5.3 China Enteral Nutrition Drug Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Enteral Nutrition Drug Sales Value, 2019-2030

6.6.2 Japan Enteral Nutrition Drug Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Enteral Nutrition Drug Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Enteral Nutrition Drug Sales Value, 2019-2030

6.7.2 South Korea Enteral Nutrition Drug Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Enteral Nutrition Drug Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Enteral Nutrition Drug Sales Value, 2019-2030

6.8.2 Southeast Asia Enteral Nutrition Drug Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Enteral Nutrition Drug Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Enteral Nutrition Drug Sales Value, 2019-2030

6.9.2 India Enteral Nutrition Drug Sales Value by Type (%), 2023 VS 2030

6.9.3 India Enteral Nutrition Drug Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Hospira Inc

7.1.1 Hospira Inc Profile

7.1.2 Hospira Inc Main Business

7.1.3 Hospira Inc Enteral Nutrition Drug Products, Services and Solutions

7.1.4 Hospira Inc Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.1.5 Hospira Inc Recent Developments

7.2 Fresenius Kabi

7.2.1 Fresenius Kabi Profile

7.2.2 Fresenius Kabi Main Business

7.2.3 Fresenius Kabi Enteral Nutrition Drug Products, Services and Solutions

7.2.4 Fresenius Kabi Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.2.5 Fresenius Kabi Recent Developments

7.3 Danone

7.3.1 Danone Profile

7.3.2 Danone Main Business

7.3.3 Danone Enteral Nutrition Drug Products, Services and Solutions

7.3.4 Danone Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.3.5 Knowmedical Recent Developments

7.4 Knowmedical

7.4.1 Knowmedical Profile

7.4.2 Knowmedical Main Business

7.4.3 Knowmedical Enteral Nutrition Drug Products, Services and Solutions

7.4.4 Knowmedical Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.4.5 Knowmedical Recent Developments

7.5 Nestlé

7.5.1 Nestlé Profile

7.5.2 Nestlé Main Business

7.5.3 Nestlé Enteral Nutrition Drug Products, Services and Solutions

7.5.4 Nestlé Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.5.5 Nestlé Recent Developments

7.6 B. Braun Melsungen AG

7.6.1 B. Braun Melsungen AG Profile

7.6.2 B. Braun Melsungen AG Main Business

7.6.3 B. Braun Melsungen AG Enteral Nutrition Drug Products, Services and Solutions

7.6.4 B. Braun Melsungen AG Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.6.5 B. Braun Melsungen AG Recent Developments

7.7 Abbott

7.7.1 Abbott Profile

7.7.2 Abbott Main Business

7.7.3 Abbott Enteral Nutrition Drug Products, Services and Solutions

7.7.4 Abbott Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.7.5 Abbott Recent Developments

7.8 Otsuka Pharmaceutical India Private Limited

7.8.1 Otsuka Pharmaceutical India Private Limited Profile

7.8.2 Otsuka Pharmaceutical India Private Limited Main Business

7.8.3 Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Products, Services and Solutions

7.8.4 Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.8.5 Otsuka Pharmaceutical India Private Limited Recent Developments

7.9 NUTRICHEM DIÄT + PHARMA GMBH

7.9.1 NUTRICHEM DIÄT + PHARMA GMBH Profile

7.9.2 NUTRICHEM DIÄT + PHARMA GMBH Main Business

7.9.3 NUTRICHEM DIÄT + PHARMA GMBH Enteral Nutrition Drug Products, Services and Solutions

7.9.4 NUTRICHEM DIÄT + PHARMA GMBH Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.9.5 NUTRICHEM DIÄT + PHARMA GMBH Recent Developments

7.10 Delta Drugs

7.10.1 Delta Drugs Profile

7.10.2 Delta Drugs Main Business

7.10.3 Delta Drugs Enteral Nutrition Drug Products, Services and Solutions

7.10.4 Delta Drugs Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.10.5 Delta Drugs Recent Developments

7.11 Baxter

7.11.1 Baxter Profile

7.11.2 Baxter Main Business

7.11.3 Baxter Enteral Nutrition Drug Products, Services and Solutions

7.11.4 Baxter Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.11.5 Baxter Recent Developments

7.12 Allergan

7.12.1 Allergan Profile

7.12.2 Allergan Main Business

7.12.3 Allergan Enteral Nutrition Drug Products, Services and Solutions

7.12.4 Allergan Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.12.5 Allergan Recent Developments

7.13 Actavis Inc.

7.13.1 Actavis Inc. Profile

7.13.2 Actavis Inc. Main Business

7.13.3 Actavis Inc. Enteral Nutrition Drug Products, Services and Solutions

7.13.4 Actavis Inc. Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.13.5 Actavis Inc. Recent Developments

7.14 Grifols, S.A.

7.14.1 Grifols, S.A. Profile

7.14.2 Grifols, S.A. Main Business

7.14.3 Grifols, S.A. Enteral Nutrition Drug Products, Services and Solutions

7.14.4 Grifols, S.A. Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.14.5 Grifols, S.A. Recent Developments

7.15 Vifor Pharma

7.15.1 Vifor Pharma Profile

7.15.2 Vifor Pharma Main Business

7.15.3 Vifor Pharma Enteral Nutrition Drug Products, Services and Solutions

7.15.4 Vifor Pharma Enteral Nutrition Drug Revenue (US$ Million) & (2019-2024)

7.15.5 Vifor Pharma Recent Developments

8 Industry Chain Analysis

8.1 Enteral Nutrition Drug Industrial Chain

8.2 Enteral Nutrition Drug Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Enteral Nutrition Drug Sales Model

8.5.2 Sales Channel

8.5.3 Enteral Nutrition Drug Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Otsuka Pharmaceutical India Private Limited

NUTRICHEM DIÄT + PHARMA GMBH

Delta Drugs

List of Tables

Table 1. Enteral Nutrition Drug Market Trends

Table 2. Enteral Nutrition Drug Market Drivers & Opportunity

Table 3. Enteral Nutrition Drug Market Challenges

Table 4. Enteral Nutrition Drug Market Restraints

Table 5. Global Enteral Nutrition Drug Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Enteral Nutrition Drug Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Enteral Nutrition Drug Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Enteral Nutrition Drug Product Type

Table 9. Key Companies Time to Begin Mass Production of Enteral Nutrition Drug

Table 10. Global Enteral Nutrition Drug Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enteral Nutrition Drug as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Enteral Nutrition Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Enteral Nutrition Drug Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Enteral Nutrition Drug Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Enteral Nutrition Drug Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Enteral Nutrition Drug Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Enteral Nutrition Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Enteral Nutrition Drug Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Enteral Nutrition Drug Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Enteral Nutrition Drug Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Enteral Nutrition Drug Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Enteral Nutrition Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Enteral Nutrition Drug Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Enteral Nutrition Drug Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Enteral Nutrition Drug Sales Value by Region (2019-2024) & (%)

Table 27. Global Enteral Nutrition Drug Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Enteral Nutrition Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Enteral Nutrition Drug Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Enteral Nutrition Drug Sales Value, (2025-2030) & (US$ Million)

Table 31. Hospira Inc Basic Information List

Table 32. Hospira Inc Description and Business Overview

Table 33. Hospira Inc Enteral Nutrition Drug Products, Services and Solutions

Table 34. Revenue (US$ Million) in Enteral Nutrition Drug Business of Hospira Inc (2019-2024)

Table 35. Hospira Inc Recent Developments

Table 36. Fresenius Kabi Basic Information List

Table 37. Fresenius Kabi Description and Business Overview

Table 38. Fresenius Kabi Enteral Nutrition Drug Products, Services and Solutions

Table 39. Revenue (US$ Million) in Enteral Nutrition Drug Business of Fresenius Kabi (2019-2024)

Table 40. Fresenius Kabi Recent Developments

Table 41. Danone Basic Information List

Table 42. Danone Description and Business Overview

Table 43. Danone Enteral Nutrition Drug Products, Services and Solutions

Table 44. Revenue (US$ Million) in Enteral Nutrition Drug Business of Danone (2019-2024)

Table 45. Danone Recent Developments

Table 46. Knowmedical Basic Information List

Table 47. Knowmedical Description and Business Overview

Table 48. Knowmedical Enteral Nutrition Drug Products, Services and Solutions

Table 49. Revenue (US$ Million) in Enteral Nutrition Drug Business of Knowmedical (2019-2024)

Table 50. Knowmedical Recent Developments

Table 51. Nestlé Basic Information List

Table 52. Nestlé Description and Business Overview

Table 53. Nestlé Enteral Nutrition Drug Products, Services and Solutions

Table 54. Revenue (US$ Million) in Enteral Nutrition Drug Business of Nestlé (2019-2024)

Table 55. Nestlé Recent Developments

Table 56. B. Braun Melsungen AG Basic Information List

Table 57. B. Braun Melsungen AG Description and Business Overview

Table 58. B. Braun Melsungen AG Enteral Nutrition Drug Products, Services and Solutions

Table 59. Revenue (US$ Million) in Enteral Nutrition Drug Business of B. Braun Melsungen AG (2019-2024)

Table 60. B. Braun Melsungen AG Recent Developments

Table 61. Abbott Basic Information List

Table 62. Abbott Description and Business Overview

Table 63. Abbott Enteral Nutrition Drug Products, Services and Solutions

Table 64. Revenue (US$ Million) in Enteral Nutrition Drug Business of Abbott (2019-2024)

Table 65. Abbott Recent Developments

Table 66. Otsuka Pharmaceutical India Private Limited Basic Information List

Table 67. Otsuka Pharmaceutical India Private Limited Description and Business Overview

Table 68. Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Products, Services and Solutions

Table 69. Revenue (US$ Million) in Enteral Nutrition Drug Business of Otsuka Pharmaceutical India Private Limited (2019-2024)

Table 70. Otsuka Pharmaceutical India Private Limited Recent Developments

Table 71. NUTRICHEM DIÄT + PHARMA GMBH Basic Information List

Table 72. NUTRICHEM DIÄT + PHARMA GMBH Description and Business Overview

Table 73. NUTRICHEM DIÄT + PHARMA GMBH Enteral Nutrition Drug Products, Services and Solutions

Table 74. Revenue (US$ Million) in Enteral Nutrition Drug Business of NUTRICHEM DIÄT + PHARMA GMBH (2019-2024)

Table 75. NUTRICHEM DIÄT + PHARMA GMBH Recent Developments

Table 76. Delta Drugs Basic Information List

Table 77. Delta Drugs Description and Business Overview

Table 78. Delta Drugs Enteral Nutrition Drug Products, Services and Solutions

Table 79. Revenue (US$ Million) in Enteral Nutrition Drug Business of Delta Drugs (2019-2024)

Table 80. Delta Drugs Recent Developments

Table 81. Baxter Basic Information List

Table 82. Baxter Description and Business Overview

Table 83. Baxter Enteral Nutrition Drug Products, Services and Solutions

Table 84. Revenue (US$ Million) in Enteral Nutrition Drug Business of Baxter (2019-2024)

Table 85. Baxter Recent Developments

Table 86. Allergan Basic Information List

Table 87. Allergan Description and Business Overview

Table 88. Allergan Enteral Nutrition Drug Products, Services and Solutions

Table 89. Revenue (US$ Million) in Enteral Nutrition Drug Business of Allergan (2019-2024)

Table 90. Allergan Recent Developments

Table 91. Actavis Inc. Basic Information List

Table 92. Actavis Inc. Description and Business Overview

Table 93. Actavis Inc. Enteral Nutrition Drug Products, Services and Solutions

Table 94. Revenue (US$ Million) in Enteral Nutrition Drug Business of Actavis Inc. (2019-2024)

Table 95. Actavis Inc. Recent Developments

Table 96. Grifols, S.A. Basic Information List

Table 97. Grifols, S.A. Description and Business Overview

Table 98. Grifols, S.A. Enteral Nutrition Drug Products, Services and Solutions

Table 99. Revenue (US$ Million) in Enteral Nutrition Drug Business of Grifols, S.A. (2019-2024)

Table 100. Grifols, S.A. Recent Developments

Table 101. Vifor Pharma Basic Information List

Table 102. Vifor Pharma Description and Business Overview

Table 103. Vifor Pharma Enteral Nutrition Drug Products, Services and Solutions

Table 104. Revenue (US$ Million) in Enteral Nutrition Drug Business of Vifor Pharma (2019-2024)

Table 105. Vifor Pharma Recent Developments

Table 106. Key Raw Materials Lists

Table 107. Raw Materials Key Suppliers Lists

Table 108. Enteral Nutrition Drug Downstream Customers

Table 109. Enteral Nutrition Drug Distributors List

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

Table 113. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Enteral Nutrition Drug Product Picture

Figure 2. Global Enteral Nutrition Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Enteral Nutrition Drug Sales Value (2019-2030) & (US$ Million)

Figure 4. Enteral Nutrition Drug Report Years Considered

Figure 5. Global Enteral Nutrition Drug Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Enteral Nutrition Drug Revenue in 2023

Figure 7. Enteral Nutrition Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Adults Picture

Figure 9. Children Picture

Figure 10. Global Enteral Nutrition Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Enteral Nutrition Drug Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Hospitals

Figure 13. Product Picture of Clinics

Figure 14. Product Picture of Pharmaceutical Companies

Figure 15. Product Picture of Others

Figure 16. Global Enteral Nutrition Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Enteral Nutrition Drug Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Enteral Nutrition Drug Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Enteral Nutrition Drug Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Enteral Nutrition Drug Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Enteral Nutrition Drug Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Enteral Nutrition Drug Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Enteral Nutrition Drug Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Enteral Nutrition Drug Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Enteral Nutrition Drug Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Enteral Nutrition Drug Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Enteral Nutrition Drug Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Enteral Nutrition Drug Sales Value (%), (2019-2030)

Figure 29. United States Enteral Nutrition Drug Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Enteral Nutrition Drug Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Enteral Nutrition Drug Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Enteral Nutrition Drug Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Enteral Nutrition Drug Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Enteral Nutrition Drug Sales Value by Application (%), 2023 VS 2030

Figure 35. China Enteral Nutrition Drug Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Enteral Nutrition Drug Sales Value by Type (%), 2023 VS 2030

Figure 37. China Enteral Nutrition Drug Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Enteral Nutrition Drug Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Enteral Nutrition Drug Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Enteral Nutrition Drug Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Enteral Nutrition Drug Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Enteral Nutrition Drug Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Enteral Nutrition Drug Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Enteral Nutrition Drug Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Enteral Nutrition Drug Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Enteral Nutrition Drug Sales Value by Application (%), 2023 VS 2030

Figure 47. India Enteral Nutrition Drug Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Enteral Nutrition Drug Sales Value by Type (%), 2023 VS 2030

Figure 49. India Enteral Nutrition Drug Sales Value by Application (%), 2023 VS 2030

Figure 50. Enteral Nutrition Drug Industrial Chain

Figure 51. Enteral Nutrition Drug Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-28S13269

Mon Oct 21 00:00:00 UTC 2024

Add to Cart

Female Nutritional Supplements - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-10W13520

Mon Oct 21 00:00:00 UTC 2024

Add to Cart

Hydrolyzed Protein Infant Formula - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-39V13712

Mon Oct 21 00:00:00 UTC 2024

Add to Cart

Vitamin H (Biotin) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-16F3836

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Enteral Nutrition Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-19W13069

Enteral Nutrition Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Enteral Nutrition Drug - Market Size

Enteral Nutrition Drug - Market

Report Scope

Scope of Enteral Nutrition Drug - Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Enteral Nutrition Drug - Market report?

What are the Application segmentation covered in the Enteral Nutrition Drug - Market report?

What are the Type segmentation covered in the Enteral Nutrition Drug - Market report?

FEATURED COMPANIES

RELATED REPORTS